Acquired Hemophilia Associated with Rheumatic Diseases: A Case-Based Systematic Review

References

• O’Connor CR. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: a potential cause of life-threatening hemorrhage. Semin Arthritis Rheum. 2015;44(6):695–709. doi:10.1016/j.semarthrit.2014.11.008
   PubMed Web of Science ®Google Scholar
• Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol. 2001;5(4):389–431. doi:10.1046/j.1468-0734.2001.00049.x
   PubMedGoogle Scholar
• Braunert L, Bruegel M, Pfrepper C, et al. Rituximab in der Behandlung der erworbenen Hämophilie A bei einem patienten mit polymyalgia rheumatica [Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica]. Hamostaseologie. 2010;30(Suppl 1):S40–S43. doi:10.1055/s-0037-1619069
   PubMedGoogle Scholar
• Arthanari S, Ahmad H, Nisar M. Fatal acquired hemophilia A in a patient with rheumatoid arthritis treated with Adalimumab. J Clin Rheumatol. 2012;18(1):50–51. doi:10.1097/RHU.0b013e31823ee3cd
   PubMed Web of Science ®Google Scholar
• Rezaieyazdi Z, Sharifi-Doloui D, Hashemzadeh K, et al. Acquired haemophilia A in a woman with autoimmune hepatitis and systemic lupus erythematosus: review of literature. Blood Coagul Fibrinolysis. 2011;22(8):738–741. doi:10.1097/MBC.0b013e32834a5c8e
   PubMed Web of Science ®Google Scholar
• Drobiecki A, Pasiarski M, Hus I, et al. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report. Blood Coagul Fibrinolysis. 2013;24(8):874–880. doi:10.1097/MBC.0b013e3283646635
   PubMed Web of Science ®Google Scholar
• Sebastian A, Misterska-Skóra M, Podolak-Dawidziak M, et al. Pregnancy exacerbates complications of acquired hemophilia in a patient with systemic lupus erythematosus. Postepy Dermatol Alergol. 2015;32(3):235–238. doi:10.5114/pdia.2014.40964
   PubMed Web of Science ®Google Scholar
• Cui QY, Wu TQ, Shen HS, et al. Refractory lupus nephropathy and acquired factor VIII and IX deficiencies in a patient with systemic lupus erythematosus treated with Rituximab. Haemophilia. 2017;23(6):e504–e506. doi:10.1111/hae.13232
   PubMed Web of Science ®Google Scholar
• Khodamoradi Z, Nazarinia MA, Bazdar S. Acquired hemophilia as initial presentation in a patient with systemic lupus erythematosus. Curr Rheumatol Rev. 2017;13(3):236–238. doi:10.2174/1573397113666170519121952
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Takafuta T, Kido M, et al. Successful management of recurrent bleeding with tocilizumab in an acquired hemophilia A patient with rheumatoid arthritis. Rinsho Ketsueki. 2017;58(7):738–742. doi:10.11406/rinketsu.58.738
   PubMedGoogle Scholar
• Mo L, Bao GC. Acquired factor VIII deficiency: two case reports and a review of literature. Exp Hematol Oncol. 2017;6:8. doi:10.1186/s40164-017-0068-3
   PubMed Web of Science ®Google Scholar
• Yang F, Zhou YS, Jia Y. Systemic lupus erythematosus with acquired hemophilia A: a case report. Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50(6):1108–1111.
   PubMedGoogle Scholar
• Ghozlani I, Mounach A, Ghazi M, et al. Targeting acquired hemophilia a with rheumatoid arthritis by a rituximab shot: a case report and review of the literature. Am J Case Rep. 2018;19:582–588. doi:10.12659/AJCR.908854
   PubMed Web of Science ®Google Scholar
• Wei F. Successful treatment of acquired hemophilia A associated with immune thrombocytopenia and joint hemarthrosis: a case report and literature review. Medicine. 2018;97(38):e12044. doi:10.1097/MD.0000000000012044
   PubMed Web of Science ®Google Scholar
• Zaidi ARZ, AlSheef M, Motabi IH, et al. Systemic lupus erythematosus presenting as hematoma of the hand due to acquired inhibitors to factor VIII: early and prolonged remission achieved with upfront rituximab. Cureus. 2019;11(5):e4786. doi:10.7759/cureus.4786
   PubMed Web of Science ®Google Scholar
• Shen P, Li J, Tu S, et al. Acquired hemophilia A in a woman with systemic lupus erythematosus: a case report and review of literature. Medicine. 2020;99(43):e22926. doi:10.1097/MD.0000000000022926
   PubMed Web of Science ®Google Scholar
• Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10(4):622–631. doi:10.1111/j.1538-7836.2012.04654.x
   PubMed Web of Science ®Google Scholar
• Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost. 1981;45(3):200–203. doi:10.1055/s-0038-1650169
   PubMed Web of Science ®Google Scholar
• Schep SJ, van Dijk W, Beckers E, et al. Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study. Am J Hematol. 2021;96(1):51–59. doi:10.1002/ajh.26009
   PubMed Web of Science ®Google Scholar
• Holstein K, Liu X, Smith A, et al. Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study. Blood. 2020;136(3):279–287. doi:10.1182/blood.2019003639
   PubMed Web of Science ®Google Scholar
• Mahendra A, Padiolleau-Lefevre S, Kaveri SV, et al. Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A? Br J Haematol. 2012;156(1):3–12. doi:10.1111/j.1365-2141.2011.08890.x
   PubMed Web of Science ®Google Scholar
• Collins P, Baudo F, Knoebl P, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood. 2012;120(1):47–55. doi:10.1182/blood-2012-02-409185
   PubMed Web of Science ®Google Scholar
• Leebeek FWG. New developments in diagnosis and management of acquired hemophilia and acquired von Willebrand Syndrome. Hemasphere. 2021;5(6):e586. doi:10.1097/HS9.0000000000000586
   PubMed Web of Science ®Google Scholar
• Hay CR. Acquired haemophilia. Bailliere’s Clin Haematol. 1998;11(2):287–303. doi:10.1016/S0950-3536(98)80049-8
   PubMed Web of Science ®Google Scholar